STOXIL Drug Patent Profile
✉ Email this page to a colleague
When do Stoxil patents expire, and when can generic versions of Stoxil launch?
Stoxil is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in STOXIL is idoxuridine. There are two drug master file entries for this compound. Additional details are available on the idoxuridine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STOXIL?
- What are the global sales for STOXIL?
- What is Average Wholesale Price for STOXIL?
Summary for STOXIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 115 |
| Patent Applications: | 4,055 |
| DailyMed Link: | STOXIL at DailyMed |
US Patents and Regulatory Information for STOXIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | STOXIL | idoxuridine | OINTMENT;OPHTHALMIC | 015868-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | STOXIL | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 013934-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
